在巴西Juiz de Fora市商业获得的含有芦丁的固体药物形式的生物制药技术和物理性质

IF 0.1 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Thiago Maurício de Souza Pinto, F. A. Almeida, Julianna Oliveira de Lucas Xavier, Glauciemar Del-Vechio-Vieira, A. L. S. M. Araújo, José de Jesus Ribeiro Gomes de Pinho, M. Alves, O. Sousa
{"title":"在巴西Juiz de Fora市商业获得的含有芦丁的固体药物形式的生物制药技术和物理性质","authors":"Thiago Maurício de Souza Pinto, F. A. Almeida, Julianna Oliveira de Lucas Xavier, Glauciemar Del-Vechio-Vieira, A. L. S. M. Araújo, José de Jesus Ribeiro Gomes de Pinho, M. Alves, O. Sousa","doi":"10.4025/actascihealthsci.v42i1.52212","DOIUrl":null,"url":null,"abstract":"Rutin is a flavonoid used in clinical practice to treat capillary fragility and prevent bleeding due to its wide variety of pharmacological actions, including antioxidant, anti-inflammatory, anti-allergic, antiproliferative, and anticarcinogenic activities. In this study, the biopharmacotechnical and physical properties of film-coated tablets containing rutin marketed in drugstores were evaluated. Using samples from three batches called A, B and C, we determined the average weight, disintegration time, hardness, content and dissolution profile, and kinetics of the tablets. The samples demonstrated average weight of 457.45 ± 12.32 to 449.15 ± 8.95 mg; disintegration time, 30.17 ± 2.14 to 15.17 ± 2.14 min; hardness, 1.92 ± 0.55 to 1.69 ± 0.36 Kgf; and rutin content, 18.34 ± 1.21 to 15.66 ± 1.29 mg. After 90 min, the dissolution profile showed 52.65, 41.80, and 79.2% for A, B, and C, respectively. The results imply that the non-conformities of the tested products can significantly compromise the drug’s therapeutic efficacy.","PeriodicalId":42839,"journal":{"name":"ACTA SCIENTIARUM-HEALTH SCIENCES","volume":"3 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2020-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Biopharmacotechnical and physical properties of solid pharmaceutical forms containing rutin commercially acquired in Juiz de Fora city, Brazil\",\"authors\":\"Thiago Maurício de Souza Pinto, F. A. Almeida, Julianna Oliveira de Lucas Xavier, Glauciemar Del-Vechio-Vieira, A. L. S. M. Araújo, José de Jesus Ribeiro Gomes de Pinho, M. Alves, O. Sousa\",\"doi\":\"10.4025/actascihealthsci.v42i1.52212\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rutin is a flavonoid used in clinical practice to treat capillary fragility and prevent bleeding due to its wide variety of pharmacological actions, including antioxidant, anti-inflammatory, anti-allergic, antiproliferative, and anticarcinogenic activities. In this study, the biopharmacotechnical and physical properties of film-coated tablets containing rutin marketed in drugstores were evaluated. Using samples from three batches called A, B and C, we determined the average weight, disintegration time, hardness, content and dissolution profile, and kinetics of the tablets. The samples demonstrated average weight of 457.45 ± 12.32 to 449.15 ± 8.95 mg; disintegration time, 30.17 ± 2.14 to 15.17 ± 2.14 min; hardness, 1.92 ± 0.55 to 1.69 ± 0.36 Kgf; and rutin content, 18.34 ± 1.21 to 15.66 ± 1.29 mg. After 90 min, the dissolution profile showed 52.65, 41.80, and 79.2% for A, B, and C, respectively. The results imply that the non-conformities of the tested products can significantly compromise the drug’s therapeutic efficacy.\",\"PeriodicalId\":42839,\"journal\":{\"name\":\"ACTA SCIENTIARUM-HEALTH SCIENCES\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2020-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACTA SCIENTIARUM-HEALTH SCIENCES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4025/actascihealthsci.v42i1.52212\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACTA SCIENTIARUM-HEALTH SCIENCES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4025/actascihealthsci.v42i1.52212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 1

摘要

芦丁是一种黄酮类化合物,由于其广泛的药理作用,包括抗氧化、抗炎、抗过敏、抗增殖和抗癌活性,在临床实践中用于治疗毛细血管脆弱和预防出血。本研究对市场上销售的芦丁薄膜包衣片的生物制药技术和物理性能进行了评价。采用A、B、C三批样品,测定了片剂的平均重量、崩解时间、硬度、含量、溶出度及动力学。样品的平均重量为457.45±12.32 ~ 449.15±8.95 mg;崩解时间:30.17±2.14 ~ 15.17±2.14 min;硬度:1.92±0.55 ~ 1.69±0.36 Kgf;芦丁含量为18.34±1.21 ~ 15.66±1.29 mg。90 min后,A、B和C的溶出率分别为52.65%、41.80%和79.2%。结果表明,测试产品的不合格会显著影响药物的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Biopharmacotechnical and physical properties of solid pharmaceutical forms containing rutin commercially acquired in Juiz de Fora city, Brazil
Rutin is a flavonoid used in clinical practice to treat capillary fragility and prevent bleeding due to its wide variety of pharmacological actions, including antioxidant, anti-inflammatory, anti-allergic, antiproliferative, and anticarcinogenic activities. In this study, the biopharmacotechnical and physical properties of film-coated tablets containing rutin marketed in drugstores were evaluated. Using samples from three batches called A, B and C, we determined the average weight, disintegration time, hardness, content and dissolution profile, and kinetics of the tablets. The samples demonstrated average weight of 457.45 ± 12.32 to 449.15 ± 8.95 mg; disintegration time, 30.17 ± 2.14 to 15.17 ± 2.14 min; hardness, 1.92 ± 0.55 to 1.69 ± 0.36 Kgf; and rutin content, 18.34 ± 1.21 to 15.66 ± 1.29 mg. After 90 min, the dissolution profile showed 52.65, 41.80, and 79.2% for A, B, and C, respectively. The results imply that the non-conformities of the tested products can significantly compromise the drug’s therapeutic efficacy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACTA SCIENTIARUM-HEALTH SCIENCES
ACTA SCIENTIARUM-HEALTH SCIENCES PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
0.40
自引率
0.00%
发文量
30
审稿时长
40 weeks
期刊介绍: The journal publishes original papers in Health Sciences, such as Clinical Analyses; Physical Education, Nursing, Pharmacy; Pharmacology, Phoniatry and Audiology, Physiotherapy and Occupational Therapy, Medicine, Nutrition, Dentistry and Public Health Policies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信